JDOC Fees and Costs — JPMorgan Healthcare Leaders ETF
Data updated: 2026-09-28
The net expense ratio is 0.65%. There are no sales loads or redemption fees. In fiscal 2025 the fund paid $3K in broker commissions, 0.0336% of average net assets, and portfolio turnover was 92%.
JDOC Fees and Expenses
Annual operating expenses and sales charges of JDOC. Prospectus, as of October 31, 2025.
| Annual operating expenses | |
|---|---|
| Management fee | 0.65% |
| 12b-1 fee | — |
| Other expenses | — |
| Gross expense ratio | 0.65% |
| Fee waiver | — |
| Net expense ratio | 0.65% |
| Sales charges | |
|---|---|
| Max front load | — |
| Max deferred load | — |
| Redemption fee | — |
| Expense limitation in place (N-CEN) | Yes |
| Fees waived or reduced during the year | Yes |
| Waived fees subject to recoupment | No |
JDOC Costs Over Time
On $10,000 invested in JDOC, assuming 5% a year before costs, total costs come to $430 over 5 years, cutting the return by 0.72% a year. Illustration, not a forecast: it assumes today's net expense ratio throughout (a fee waiver may end).
| $10,000 invested | Sell after 1 year | Sell after 3 years | Sell after 5 years |
|---|---|---|---|
| Value before costs | $10,500 | $11,576 | $12,763 |
| Fund expenses (net expense ratio 0.65%) | $68 | $214 | $372 |
| Trading costs (broker commissions) | $4 | $11 | $19 |
| Lost growth on money paid in costs | $0 | $11 | $39 |
| Total costs | $72 | $236 | $430 |
| Value after costs | $10,428 | $11,340 | $12,333 |
| Impact on return, per year | 0.72% | 0.72% | 0.72% |
JDOC Trading Costs
Brokerage costs reported on SEC Form N-CEN for the fiscal year ending October 31, 2025.
- Explicit cost rate (commissions ÷ average net assets): 0.0336%
- Total broker commissions: $3K
- Bought from dealers (principal trades, not a cost): $52K
- Portfolio turnover (prospectus): 92%
- Securities lending: none during the year
JDOC Agency Brokers
Commissions paid.
| Broker | Amount | Share |
|---|---|---|
| Jefferies LLC | $479 | 23.72% |
| Goldman Sachs & Co. LLC | $360 | 17.86% |
| Wells Fargo Securities, LLC | $242 | 12.00% |
| Merrill Lynch, Pierce, Fenner & Smith Inc. | $241 | 11.94% |
| UBS Securities LLC | $218 | 10.79% |
| Barclays Capital, Inc. | $132 | 6.52% |
| Liquidnet, Inc. | $92 | 4.56% |
| Citigroup Global Markets Inc. | $91 | 4.52% |
| RBC Capital Markets, LLC | $90 | 4.48% |
| BTIG, LLC | $73 | 3.61% |
JDOC Dealer Counterparties
Securities bought directly from dealers (principal trades).
| Broker | Amount | Share |
|---|---|---|
| Jefferies LLC | $46K | 88.78% |
| Leerink Partners LLC | $4K | 8.29% |
| Goldman Sachs & Co. LLC | $2K | 2.93% |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.